Invention Grant
- Patent Title: Method for determining FXIII levels as a prognostic biomarker in acute myocardial infarction
-
Application No.: US15228130Application Date: 2016-08-04
-
Publication No.: US10067132B2Publication Date: 2018-09-04
- Inventor: Donato Gemmati
- Applicant: Donato Gemmati
- Agency: Nixon & Vanderhye PC
- Priority: ITTO2013A0532 20130627
- Main IPC: G01N33/53
- IPC: G01N33/53 ; A61K38/36 ; A61P9/10 ; G01N33/573 ; G01N33/86 ; C07K14/745 ; C07K16/36
Abstract:
A diagnostic method for determining prognosis of a myocardial infarcted patient, wherein the amounts of FXIII protein are determined on the day of myocardial infarction (t0) and at least on the following three days (t1 to t3), wherein a lowering of FXIII amount on any one of t0 to t3 below a threshold value is indicative of an increased risk of poor prognosis.
Public/Granted literature
- US20160363592A1 KIT FOR DETERMINING FXIII LEVELS AS A PROGNOSTIC BIOMARKER IN ACUTE MYOCARDIAL INFARCTION Public/Granted day:2016-12-15
Information query
IPC分类:
